PRA Health Sciences to Report Third Quarter 2017 Earnings
October 09 2017 - 3:46PM
PRA Health Sciences, Inc. (NASDAQ:PRAH) will release its third
quarter 2017 results after the market closes on Wednesday, October
25, 2017. The Company will also host a conference call on Thursday,
October 26, 2017 at 8:00 a.m. (ET) to discuss the results with
members of the investment community.
To participate via telephone, investors and analysts should dial
(877) 930-8062 within the United States or (253) 336-7647 outside
the United States approximately 10 minutes prior to the call start
time. The conference ID for the call is 98635318. An audio replay
of the call will be available for one week following the call and
can be accessed by dialing (855) 859-2056 within the United States
or (404) 537-3406 outside the United States. The replay ID is
98635318.
A live audio broadcast will be available on the investor
relations section of the PRA Health Sciences website. Following the
teleconference, an audio playback of the call will be available at
the same website.
ABOUT PRA HEALTH SCIENCES
PRA is one of the world's leading global contract research
organizations, by revenue, providing outsourced clinical
development services to the biotechnology and pharmaceutical
industries. PRA’s global clinical development platform includes
More than 70 offices across North America, Europe, Asia, Latin
America, South Africa, Australia and the Middle East, and over
14,000 employees worldwide. Since 2000, PRA has participated in
approximately 3,500 clinical trials worldwide. In addition, PRA has
participated in the pivotal or supportive trials that led to U.S.
Food and Drug Administration or international regulatory approval
of more than 70 drugs. To learn more about PRA, please visit
www.prahs.com.
INVESTOR INQUIRIES: InvestorRelations@prahs.com
PRA Health Sciences (NASDAQ:PRAH)
Historical Stock Chart
From Aug 2024 to Sep 2024
PRA Health Sciences (NASDAQ:PRAH)
Historical Stock Chart
From Sep 2023 to Sep 2024